Drugs / Dendritic cell application
last change Oct 2011 re-read 3 minutes ago

Dendritic cell application

Vaccine

Developed for
prostate cancer
Investigated by
Cantonal Hospital of St. Gallen

Trials 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01897207 Nov 2002 → Aug 2009 prostate cancer Cantonal Hospital of St. Gallen Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Dendritic cell application ClinicalTrials.gov intervention name — accepted as the source's own label NCT01897207 ↗
Modality Vaccine “Vaccination With Antigen Loaded Dendritic Cells (DCs)” NCT01897207 ↗
Route Subcutaneous “S.C. injection of peptide pulsed autologous dendritic cells” NCT01897207 ↗